Events

Recall of Device Recall KyphX HVR Bone Cement

According to U.S. Food and Drug Administration, this recall involved a device in United States that was produced by Medtronic Spine LLC, formerly Kyphon Inc.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    54384
  • Event Risk Class
    Class 2
  • Event Number
    Z-1625-2011
  • Event Initiated Date
    2009-11-10
  • Event Date Posted
    2011-03-11
  • Event Status
    Terminated
  • Event Country
    United States
  • Event Terminated Date
    2011-03-11
  • Event Source
    USFDA
  • Event Source URL
    https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=88623
  • Notes / Alerts
    U.S. data is current through June 2018. All of the data comes from the U.S. Food and Drug Administration, except for the category Manufacturer Parent Company.
    The Parent Company was added by ICIJ.
    The parent company information is based on 2017 public records.
  • Extra notes in the data
    Cement, bone, vertebroplasty - Product Code JDZ
  • Reason
    Product may not reach proper viscosity (dough state) and inconsistency or lack of homogeneity during cement preparation and during delivery period.
  • Action
    The firm, Medtronic Spine LLC, sent an "URGENT DEVICE RECALL NOTICE" dated November 9, 2009 to the customers. The notice described the product, problem and actions to be taken. The customers were instructed to return the affected lots to Medtronic Spine; to not use any of the affected product that they may have received (Medtronic will replace any affected product in their inventory), the customer should contact their Medtronic Spine sales representative or customer service at [866-959-7466 or for geography] for assistance with replacement product, and complete and return the URGENT DEVICE RECALL NOTICE: Action Required form to Medtronic Spine LLC via fax at (408) 543-6192 or mail to: Medtronic Spine LLC, Attn: Recall Coordinator, 1221 Crossman Avenue, Sunnyvale, CA 94089. If you have any questions about this notification, please do not hesitate to contact Sr. Director, Regulatory Affairs via email: pamela.n.segale@medtronic.com or phone at (408) 548-5235.

Device

Device Recall KyphX HVR Bone Cement
  • Model / Serial
    Lot Numbers: 0000776598, 0000790377, 0000790380, 0000794905, 0000794997, 0000794998, 0000794999, 0000795000, 0000802774, 0000802775, 0000819410, 0000825149, 0000828632, 0000828633, 0000841918, 0000841919, 0000842869, 0000842871, 0000848666, 0000848670, 0000858673, 0000892106, 000089859, 0000911555, 0000922990, 0000925894, 0000930458, 0000931993, 0000945996, 0000952887, 0000958800, 00009666732, 0000966734, 0000972324, 0000972325, 0000975787, 0000982884, 0000994176, 0001008470, 0001008472, 0001008598, 0001033988, 0001034877, 0001045184, 0001045187, 0001050788, 0001050789, 0001056101, 0001056102, 0001060659, 0001060662, 0001067884, 0001067886, 0001081545, 0001104034, 00841918, 88930458, J6092716, J6100426, J6101208, J6101808, J6103009, J6110310, J6110906, J6112008, J6112712, J6120108, J6121203, J6121902, J6121903, J6121904, J6121905, J6121906, J7010201, J7011107, J7011907, J7012506, J7020624, J7021509, J7022202, J7022702, J7030605, J7031401, J7031506, J7032310, J7032702, J7040213, J7041010, J7041301, J7042109, J7050101, J7050405, J7051107, J7051801, J7052511, J7060205, J7061130, J7062109, J7062708, J7070210, J7070706, J7071602, J7071906, J7072702, J7080702, J7081815, J7081816, J7082816, J7090620, J7091106, J7091208, J7091206, J7100606, J7101704, J7101705, J7110523, J7111216, J7111608, J7112823, J7120314, J7122101, J8010201, J8010402, J8010918, J8010718, J8041401, J8041705, J8042401, J8051203, J8051204, J8052915, J8052916, J8060205, J8060410, J8061208, J8010919, J8012214, J8013005, J8020117, J8020722, J8021910, J8030517, J8030518, J8031202, J8032601, J8040717, J8061209
  • Product Classification
    Orthopedic Devices
  • Device Class
    1
  • Implanted device?
    No
  • Distribution
    USA including states of: AL, AR, AZ, CA, CO, DC, FL, GA, IA, IN, KY, MA, MD, MO, MT, NC, NM, NV, NY, OH, PA, SC, TN, TX, UT, VA, WI, and WV; and countries including: Argentina, Austria, Belgium, Brazil, Canada, Chile, Cyprus, Czech Republic, Denmark, Finland, France, Germany, Greece, Honduras, Hong Kong, Hungary, India, Iran, Ireland, Israel, Italy, Ivory Coast, Jordan, Kuwait, Lebanon, Luxembourg, Lybia, Malaysia, Malta, Mexico, Morocco, Netherlands, New Caledonia, Norway, Panama, Philippines, Poland, Portugal, Puerto Rico, Reunion, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, Spain, Sweden, Turkey, United Arab Emirates, United Kingdom and Vietnam.
  • Product Description
    Medtronic brand KyphX HV-R Bone Cement with Kyphon mixer, a polymethyl bone cement kit consisting of a quantity of powder (20 g) and a volume of liquid (10 ml/9 g) mixed in a Kyphon mixer for up to two minutes. Model Number: CO1B; Manufactured by Elmdown LTD, London, England, for Medtronic Spine LLC, Sunnyvale, CA. || Product is a medical device used during balloon kyphoplasty to cement structures in fractured vertebral bodies.
  • Manufacturer
    Medtronic Spine LLC, formerly Kyphon Inc

Manufacturer

Medtronic Spine LLC, formerly Kyphon Inc
  • Manufacturer Address
    Medtronic Spine LLC, formerly Kyphon Inc, 1221 Crossman Ave, Sunnyvale CA 94089-1103
  • Manufacturer Parent Company (2017)
    Medtronic plc
  • Manufacturer comment
    “If our surveillance systems identify a potential performance issue, our personnel promptly evaluate the problem, including, when appropriate, conducting root cause investigations and internal testing to assess whether the product continues to meet specifications and defined performance criteria,” Medtronic told ICIJ in a statement. “In some cases, based on this evaluation, Medtronic may determine that a recall is necessary.” The company said that it communicates with healthcare providers and/or patients and provide recommendations to address such issues. Medtronic noted that these communications can include letters, emails, calls, press releases, physician notifications and social media postings, as well as informing the FDA and other regulators of the actions.
  • Source
    USFDA